Literature DB >> 11041329

Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls.

S Haghighi1, O Andersen, L Rosengren, T Bergström, J Wahlström, S Nilsson.   

Abstract

We found that 19% (9/47) of healthy siblings of patients with clinically definite multiple sclerosis had an intrathecal immunological reaction with two or more 2 CSF-enriched oligoclonal bands (OCBs), in contrast to (4%) (2/50) unrelated healthy controls. Furthermore, in this group of nine healthy sibs the measles CSF IgG antibody titers were higher than that of the other sibs and that of controls. There were also differences in the serum titers for measles IgG antibody, which were higher in the group of all healthy sibs than in healthy volunteers, and (as with CSF titers) higher in the subgroup of healthy sibs with two or more 2 CSF-enriched OCBs than the other sibs. Thus a significant proportion of healthy siblings to MS patients have a partially hyperimmune condition similar to that occurring in MS, which in 19% manifested itself as an OCB reaction, in 9% as increased CSF measles IgG antibody titers, and in 21% as increased serum measles IgG antibody titers, these phenomena tending to occur in the same individuals. This condition is characterized by CSF-enriched OCBs with undefined specificity, although some increased antiviral reactivity is found both in the serum and CSF. While it needs further characterization, a genetic trait interacting with common infections is suggested. The recurrence risk of this condition is approximately five times higher than the 3-4% recurrence risk for manifest MS reported for sibs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041329     DOI: 10.1007/s004150070130

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.

Authors:  Sonia Chalbot; Henrik Zetterberg; Kaj Blennow; Tormod Fladby; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Neurosci Lett       Date:  2010-05-12       Impact factor: 3.046

2.  Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Authors:  An Goris; Ine Pauwels; Marte W Gustavsen; Brechtje van Son; Kelly Hilven; Steffan D Bos; Elisabeth Gulowsen Celius; Pål Berg-Hansen; Jan Aarseth; Kjell-Morten Myhr; Sandra D'Alfonso; Nadia Barizzone; Maurizio A Leone; Filippo Martinelli Boneschi; Melissa Sorosina; Giuseppe Liberatore; Ingrid Kockum; Tomas Olsson; Jan Hillert; Lars Alfredsson; Sahl Khalid Bedri; Bernhard Hemmer; Dorothea Buck; Achim Berthele; Benjamin Knier; Viola Biberacher; Vincent van Pesch; Christian Sindic; Annette Bang Oturai; Helle Bach Søndergaard; Finn Sellebjerg; Poul Erik H Jensen; Manuel Comabella; Xavier Montalban; Jennifer Pérez-Boza; Sunny Malhotra; Jeannette Lechner-Scott; Simon Broadley; Mark Slee; Bruce Taylor; Allan G Kermode; Pierre-Antoine Gourraud; Stephen J Sawcer; Bettina Kullle Andreassen; Bénédicte Dubois; Hanne F Harbo
Journal:  Brain       Date:  2015-01-22       Impact factor: 13.501

Review 3.  The immunogenetic architecture of autoimmune disease.

Authors:  An Goris; Adrian Liston
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

4.  Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart Review.

Authors:  Mattia Campana; Johanna Strauß; Susanne Münz; Tatiana Oviedo-Salcedo; Piyumi Fernando; Peter Eichhorn; Peter Falkai; Alkomiet Hasan; Elias Wagner
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

5.  IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.

Authors:  Marko Petržalka; Eva Meluzínová; Jana Libertínová; Hana Mojžišová; Jitka Hanzalová; Petra Ročková; Martin Elišák; Silvia Kmetonyová; Jan Šanda; Ondřej Sobek; Petr Marusič
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

Review 6.  Rare phenotypes in the understanding of autoimmunity.

Authors:  Yvonne Zeissig; Britt-Sabina Petersen; Andre Franke; Richard S Blumberg; Sebastian Zeissig
Journal:  Immunol Cell Biol       Date:  2016-10-11       Impact factor: 5.126

7.  The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review.

Authors:  Harald Hegen; Anne Zinganell; Michael Auer; Florian Deisenhammer
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

8.  Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis.

Authors:  Tetyana Blinder; Jan Lewerenz
Journal:  Front Neurol       Date:  2019-07-25       Impact factor: 4.003

9.  Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy.

Authors:  Michael P Pender
Journal:  Clin Transl Immunology       Date:  2020-04-06

10.  Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Authors:  Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.